A carregar...

Evidence for a stereoselective mechanism for bitopic activity by extended-length antagonists of the D(3) dopamine receptor

The D3 dopamine receptor (D3R) has been suggested as a drug target for the treatment of a number of neuropsychiatric disorders, including substance use disorders (SUD). Many D3R-selective antagonists are bivalent in nature in that they engage two distinct sites on the receptor – a primary pharmacoph...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ACS Chem Neurosci
Main Authors: Moritz, Amy E., Bonifazi, Alessandro, Guerrero, Adrian M., Kumar, Vivek, Free, R. Benjamin, Lane, J. Robert, Verma, Ravi Kumar, Shi, Lei, Newman, Amy Hauck, Sibley, David R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8262072/
https://ncbi.nlm.nih.gov/pubmed/32969645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschemneuro.0c00425
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!